Cer­tain GSK an­tibi­ot­ic brands are up for sale — re­port

Last month, GSK’s Em­ma Walm­s­ley laid the ground­work for the com­pa­ny’s planned bi­fur­ca­tion — con­sumer health­care and an R&D-fo­cused out­fit (in­clud­ing its his­tor­i­cal­ly sep­a­rate vac­cines unit) …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER